Two prostate tumor cell lines carrying ABI1 exon skipping mutations resulting in SH3 domain loss and consequential attenuation of ABL1 binding to ABI1 show loss of negative regulation of ABL1 by ABI1, resulting in increased ABL1 activation [173]. The gene discussed is ABL1; the disease is prostate neoplasm.